{
    "organizations": [],
    "uuid": "ed5704c78bd4a5a75e550d1d96b31903658d1508",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-prescient-therapeutics-updates-on/brief-prescient-therapeutics-updates-on-ptx-200-clinical-trials-idUSFWN1PL1AU",
    "ord_in_thread": 0,
    "title": "BRIEF-Prescient Therapeutics Updates On PTX-200 Clinical Trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) - Prescient Therapeutics Ltd:\n* ALL PTX-200 TRIALS NOW OFF CLINICAL HOLD & EITHER CURRENTLY RECRUITING OR IN PROCESS OF GETTING APPROVALS TO START RECRUITMENT​\n* ‍FINAL RESULTS FROM PHASE 1B TRIAL OF PTX-200 EXPECTED Q1 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-29T06:56:00.000+02:00",
    "crawled": "2018-01-29T21:59:48.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "prescient",
        "therapeutic",
        "ltd",
        "trial",
        "clinical",
        "hold",
        "either",
        "currently",
        "recruiting",
        "process",
        "getting",
        "approval",
        "start",
        "result",
        "phase",
        "1b",
        "trial",
        "expected",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}